Showing results (631-640 of 764) with videos related to

Sort By:
Pageof 77
Neurotoxicology|September 3, 2021
Neuroprotective effects of the CTK 01512-2 toxin against neurotoxicity induced by 3-nitropropionic acid in ratsFlavia Tasmin Techera Antunes, Alessandra Hubner de Souza, Emanuelle Sistherenn Caminski, et al.
Arquivos De Gastroenterologia|January 1, 1997
[Intestinal parasitosis and hepatic cirrhosis]D Gaburri, A K Gaburri, E Hubner, et al.
British Journal of Cancer|March 29, 2017
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysisUwe Pelzer, Jean-Frédéric Blanc, Davide Melisi, et al.
European Journal of Endocrinology|August 3, 2021
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDYMaria Fleseriu, Dagmar Führer-Sakel, Aart J van der Lely, et al.
Journal of Cardiovascular Translational Research|June 27, 2022
LINC01013 Is a Determinant of Fibroblast Activation and Encodes a Novel Fibroblast-Activating MicropeptideN M Quaife, S Chothani, J F Schulz, et al.
BMJ Open|October 26, 2022
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literatureMairéad G McNamara, John Bridgewater, Lipika Goyal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
Experimental Parasitology|September 2, 2020
Ovicidal in vitro activity of the fixed oil of Helianthus annus L. and the essential oil of Cuminum cyminum L. against Fasciola hepatica (Linnaeus, 1758)Maria Antonieta Machado Pereira da Silva, Fabiane Knepper Zehetmeyr, Karine Massia Pereira, et al.
Investigational New Drugs|February 12, 2017
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase CKhaldoun Almhanna, Maria Luisa Limon Miron, David Wright, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 29, 2005
A new score for predicting neonatal very low birth weight mortality risk in the NEOCOSUR South American NetworkGuillermo Marshall, Jose L Tapia, Ivonne D'Apremont, et al.
Pageof 77